Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
54.5M
-
Shares change
-
+54.5M
-
Total reported value, excl. options
-
$665M
-
Value change
-
+$665M
-
Number of buys
-
78
-
Price
-
$12.21
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q3 2021
78 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q3 2021.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.5M shares
of 107M outstanding shares and own 51% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (14M shares), D1 Capital Partners L.P. (3.51M shares), Vitruvian Partners LLP (3.33M shares), Artisan Partners Limited Partnership (3.07M shares), VANGUARD GROUP INC (2.75M shares), Montanaro Asset Management Ltd (2.55M shares), Holocene Advisors, LP (2.43M shares), RIVER & MERCANTILE ASSET MANAGEMENT LLP (2.31M shares), Nine Ten Capital Management LLC (1.9M shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.56M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.